Peptide Terminal Modifications: Acetylation and Amidation Explained
How to read terminal modification labels and avoid confusing a modified peptide with its unmodified sequence or salt form.
By PuraSynth Labs Research Team
Two research peptides can share the same residue sequence while differing at one or both ends of the chain. N-terminal acetylation and C-terminal amidation are examples of terminal modifications. They belong in the material specification, preparation record, and literature comparison.
The important first step is to identify the exact structure being described. A short sequence string may omit details that matter to the experiment.
What N-terminal acetylation means
N-terminal acetylation places an acetyl group on the amino-terminal nitrogen. It is commonly indicated by an “Ac-” annotation before the sequence, although the supplier’s notation should always be checked.
The location matters. Acetylation of a lysine side chain is not the same structural description as acetylation at the N-terminus. Thermo Fisher’s custom peptide synthesis brochure lists N-terminal acetylation, acetyl-lysine, and C-terminal amidation as distinct modification options.
What C-terminal amidation means
C-terminal amidation changes the terminal carboxyl group to a carboxamide, commonly represented as -CONH2. A sequence may show an “-NH2” ending to indicate this feature. That annotation is not an additional amino acid residue.
The IUPAC-IUB nomenclature recommendations explain that a C-terminal residue can have a terminal amide. A peptide can therefore still be described in terms of an N-terminus and C-terminus when those ends are chemically modified.
Keep three descriptions separate
- Residue sequence: the order of amino acid residues.
- Covalent modifications: changes such as terminal acetylation or amidation, with their positions specified.
- Salt form: the associated counterion description, such as acetate.
An acetate salt does not establish that the peptide is acetylated. Likewise, a product called “modified” does not identify the modification site. Use the counterion guide and sequence notation guide to keep these fields distinct.
Write an unambiguous material record
For an illustrative three-residue sequence, record the residue order as Gly-Ala-Lys and describe each terminus separately. If the intended material is N-acetylated and C-amidated, retain that full wording alongside any shorthand supplied by the manufacturer.
Also record the lot identifier, the source specification, and the molecular mass or molar mass basis used in calculations. Do not take a value from an unmodified sequence and silently reuse it for a modified material. Ask the supplier or analytical team to resolve any mismatch before preparation.
Compare evidence for the actual form
When reading a paper, look in the methods and supplementary information for the full peptide description. If one study uses a free terminus and another uses a modified terminus, preserve that difference in your notes.
A modification name alone does not predict the direction or size of a biological response. Claims about improved stability, binding, or activity need evidence for the relevant structure and experimental conditions. Do not convert a general rationale for a modification into a promise about a particular research product.
For a direct comparison, define which structural feature changes and which preparation and assay variables remain matched. Our assay controls guide can help organize the questions the experiment must answer.
Before ordering or starting work
- Confirm residue order and modification positions.
- Check both terminal groups explicitly.
- Record salt form separately.
- Match the specification to the available lot documentation.
- Resolve notation and calculation questions before use.
Frequently asked questions
Does “Ac” always identify the modification site?
Its placement and the notation convention matter. Obtain the full structural description if the abbreviation is unclear.
Are modified and unmodified peptides interchangeable?
Do not assume so. Select and document the form required by the research method.
Research use only. This article concerns laboratory identity and study planning.
Research Use Only. The information above is provided for educational purposes and describes laboratory and in-vitro research only. All compounds referenced are sold strictly as research materials — not for human or veterinary use, consumption, diagnostic, or therapeutic applications. Nothing here is medical advice.